All Stories

  1. Vaccine Potential of Mycobacterial Antigens Against Asthma
  2. The effect of adjuvants and delivery systems on Th1, Th2, Th17 and Treg cytokine responses in mice immunized with Mycobacterium tuberculosis-specific proteins
  3. Development of a potent invigorator of immune responses endowed with both preventive and therapeutic properties
  4. Immune Responses to Candidate Vaccine Antigens Delivered Through Naked Plasmid and Mycobacterial Vectors
  5. Draft Genome Sequences of Five Clinical Strains of Brucella melitensis Isolated from Patients Residing in Kuwait: TABLE 1 
  6. Association between Helicobacter pylori genotypes and severity of chronic gastritis, peptic ulcer disease and gastric mucosal interleukin-8 levels: Evidence from a study in the Middle East
  7. The Future of Mycobacterium tuberculosis-Specific Antigens/Peptides in Tuberculin Skin Testing for the Diagnosis of Tuberculosis
  8. Cellular Immune Responses to Recombinant Mycobacterium bovis BCG Constructs Expressing Major Antigens of Region of Difference 1 of Mycobacterium tuberculosis
  9. Proteins and Peptides Encoded by M. tuberculosis-Specific Genomic Regions for Immunological Diagnosis of Tuberculosis
  10. Diagnostic and Vaccine Potentials of ESAT-6 Family Proteins encoded by M. tuberculosis genomic regions absent in M. bovis BCG
  11. In silico Analysis and Experimental Validation ofMycobacterium tuberculosis-Specific Proteins and Peptides ofMycobacterium tuberculosisfor Immunological Diagnosis and Vaccine Development
  12. Su1648 Association Between H. pylori Genotypes and Severity of Chronic Gastritis, Peptic Ulcer Disease and IL-8 Induction
  13. What’s New in the Development of Tuberculosis Vaccines
  14. Molecular Cloning, Expression, Purification and Immunological Characterization of Proteins Encoded by Regions of Difference Genes of Mycobacterium tuberculosis
  15. Cytokines in response to proteins predicted in genomic regions of difference of Mycobacterium tuberculosis
  16. Characterization of human cellular immune responses toMycobacterium tuberculosisproteins encoded by genes predicted in RD15 genomic region that is absent inMycobacterium bovisBCG
  17. In silico Binding Predictions for Identification of HLA-DR-Promiscuous Regions and Epitopes of Mycobacterium tuberculosis Protein MPT64 (Rv1980c) and Their Recognition by Human Th1 Cells
  18. Mapping of Th1-Cell Epitope Regions ofMycobacterium tuberculosisProtein MPT64 (Rv1980c) Using Synthetic Peptides and T-Cell Lines fromM. tuberculosis-Infected Healthy Humans
  19. Vaccine potential ofMycobacterium tuberculosis-specific genomic regions:in vitrostudies in humans
  20. HLA-Promiscuous Th1-Cell Reactivity of MPT64 (Rv1980c), a Major Secreted Antigen of Mycobacterium tuberculosis, in Healthy Subjects
  21. Detection and Monitoring of Cytomegalovirus Infection in Renal Transplant Patients by Quantitative Real-Time PCR
  22. ProPred analysis and experimental evaluation of promiscuous T-cell epitopes of three major secreted antigens of Mycobacterium tuberculosis
  23. Recombinant and synthetic peptides to identify Mycobacterium tuberculosis antigens and epitopes of diagnostic and vaccine relevance
  24. Applications of flow cytometry on bacteria: Cell cycle kinetics, drug effects, and quantitation of antibody binding
  25. Development of new vaccines and diagnostic reagents against tuberculosis
  26. HLA-restricted immune response to mycobacterial antigens: relevance to vaccine design
  27. Extensive sequence homology between theMycobacterium lepraeLSR (12 kDa) antigen and itsMycobacterium tuberculosiscounterpart
  28. Human T cell recognition of theMycobacterium lepraeLSR antigen: epitopes and HLA restriction
  29. Isolation of recombinant phage clones expressing mycobacterial T cell antigens by screening a recombinant DNA library with human CD4+Th1 clones
  30. Mycobacterium tuberculosisreactive T cell clones from naturally converted PPD-positive healthy subjects: recognition of theM. tuberculosis16-kDa antigen
  31. Mycobacterial crossreactivity ofM. tuberculosisreactive T cell clones from naturally converted PPD positive healthy subjects
  32. Development of Improved Vaccines against Tuberculosis
  33. Identification of Mycobacterial Recombinant Antigens Recognized by Human T Cells
  34. Primary Structure and MHC Restriction of Peptide-Defined T Cell Epitopes from Recombinant Mycobacterial Protein Antigens
  35. Mapping of HLA-DR4 restricted T cell epitopes from the mycobacterial HSP60 with synthetic peptides
  36. Improved detection of mycobacterial antigens in clinical specimens by combined enzyme-linked immunosorbent assays
  37. Long-lasting T-cell reactivity to Mycobacterium leprae antigens in human volunteers vaccinated with killed M. leprae
  38. Armadillo-Derived Killed M. leprae: Candidate Vaccine Against Leprosy
  39. Mycobacterium w: Candidate Vaccine Against Leprosy with Antigens CrossReactive with Three Major Protein Antigens of Mycobacterium leprae
  40. Epstein-Barr virus mediates a switch in responsiveness to transforming growth factor, type beta, in cells of the B cell lineage
  41. Human T-cell clones recognize a major M. leprae protein antigen expressed in E. coli
  42. The role of interleukin-2 (IL-2) in the specific unresponsiveness of lepromatous leprosy to Mycobacterium leprae: studies in vitro and in vivo
  43. Reversal by Interleukin-2 of the T Cell Unresponsiveness of Lepromatous Leprosy to Mycobacterium Leprae
  44. T-cell conditioned media reverse T-cell unresponsiveness in lepromatous leprosy
  45. Recombinant Mycobacterial Antigens and Epitopes Recognized by Human T Cells
  46. T-Cell Subsets and Cytokines Interplay in Infectious Diseases: An Overview